000 01409 a2200409 4500
005 20250516132007.0
264 0 _c20140821
008 201408s 0 0 eng d
022 _a1873-7560
024 7 _a10.1016/j.eururo.2013.01.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGershman, Boris
245 0 0 _aPrediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
_h[electronic resource]
260 _bEuropean urology
_cApr 2014
300 _a683-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFollow-Up Studies
650 0 4 _aGonadal Steroid Hormones
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aSurvival Rate
700 1 _aShui, Irene M
700 1 _aStampfer, Meir
700 1 _aPlatz, Elizabeth A
700 1 _aGann, Peter H
700 1 _aSesso, Howard L
700 1 _aDuPre, Natalie
700 1 _aGiovannucci, Edward
700 1 _aMucci, Lorelei A
773 0 _tEuropean urology
_gvol. 65
_gno. 4
_gp. 683-9
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2013.01.003
_zAvailable from publisher's website
999 _c22438805
_d22438805